Nov 16, 2007 | NEWS
The company that has led in the discovery of genes that confer risk of common diseases is empowering individuals to explore their own genome Reykjavik, ICELAND, Nov. 16, 2007 – deCODE genetics (Nasdaq:DCGN) today announced the launch of deCODEme™, a pioneering service...
Nov 2, 2007 | NEWS
Tests Detect Major Common Genetic Risk Factors for Heart Attack and Stroke Orlando, Florida, November 4-7, 2007 – At this year’s Scientific Sessions of the American Heart Association, deCODE genetics (Nasdaq:DCGN) is presenting its newly launched DNA-based...
Oct 21, 2007 | NEWS
Scientists at deCODE genetics and colleagues in Iceland and Holland today report the discovery of variations in the human genome that influence pigmentation of hair, eyes and skin. By studying more than 300,000 SNPs (single-letter variants in the human genome) across...
Oct 11, 2007 | NEWS
deCODE genetics (Nasdaq:DCGN) today announced the launch of deCODE MI™, a reference laboratory test for variations in the genome (called SNPs) that the company has associated with increased risk of myocardial infarction, or heart attack. The SNPs are located on...
Oct 9, 2007 | NEWS
deCODE genetics (Nasdaq:DCGN) today announced that it has begun enrolling patients for its Phase IIa clinical trial for DG051, the company’s leukotriene A4 hydrolase inhibitor being developed for the prevention of heart attack. In Phase I studies completed earlier...
Sep 9, 2007 | NEWS
In a paper published today in the journal Science, scientists from deCODE genetics (Nasdaq:DCGN) and academic colleagues from the National University Hospital in Reykjavik and Uppsala University in Sweden report the discovery of two common single letter variations...
